Aptitude Arch Aptitude Arch

Where Better
Decisions Start

Connecting hematology oncology life science companies with healthcare professionals to share critical insights and education for improved outcomes.

Partner With Us for Success

We are the market leader in gathering and communicating the world’s growing scientific and clinical knowledge to support hematology oncology innovations and empower better decision-making.

Scientific and analytic icon

Scientific and analytic expertise

We provide thoughtful analyses, practical recommendations, and future-focused solutions

Knowledge icon

In-depth knowledge and understanding of the hematology oncology market

We turn real-world knowledge into robust, reliable, and actionable insights for improved patient care

Relationships icon

Long-standing relationships with scientific leaders

We connect life science companies with the global medical community and industry decision-makers

Support icon

Support for every step of the product life cycle

We help client teams navigate
all stages, from discovery to clinical development to commercialization and beyond

Axess Logo

Benefits for Life Science Companies

Connect with our unparalleled and proprietary network of 5,000+ oncology and hematology global key opinion leaders, healthcare providers, and market access professionals. Consultants from the Axess Network share unbiased expertise to help shape clinical innovations for improved patient care.

Learn More

Opportunities for Healthcare Professionals

Participate in consulting engagements and receive clinical insights to help shape innovations for improved patient care and outcomes. By participating in Aptitude Health programs, healthcare professionals can benchmark treatment approaches for improved clinical competency and patient care.

Learn More

World-Class Solutions for
Better Hematology Oncology 
Outcomes

We provide evidence-based solutions at the forefront of life science clinical and commercial decisions, built on our expertise, global resources, and long-standing relationships with key scientific leaders.

Best-In-Class Hematology Oncology Reports

Gain insights into the increasingly complex factors that shape patient management decisions with hundreds of business intelligence reports, covering all major tumor types and hematologic malignancies.

Explore Available Reports

Creating Value for Our Partners

Life science companies have partnered with us to deliver evidence-based solutions and commercial programs that support the global medical community and industry decision-makers.

The Latest
News & Events

Stay on top of trends and updates in hematology oncology with news highlights from around the world.

Current Management of Renal Cell Carcinoma Features Immune Checkpoint Inhibitors

Read More

November 14th, 2024
Medical Advances

Insights Into Early Breast Cancer Favor Neoadjuvant Immune Checkpoint Inhibitor Therapy

Read More

November 7th, 2024
Medical Advances

Aptitude Health Acquires Athena Meetings & Events, Organizer of the Annual UK Oncology Forum, to Strengthen Global Reach

Read More

November 1st, 2024
Aptitude Health

New FDA and EMA Oncology Drug Approvals in Q3 2024 Largely Focused on NSCLC and Other Solid Tumors

Read More

October 17th, 2024
Medical Advances

Considerations for Overall Survival Analyses in Clinical Trials

Read More

October 4th, 2024
Medical Advances

See All News & Events